Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Gastrointestinal Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT04616534
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors

Who this might be right for
Advanced Fallopian Tube CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Ovarian Carcinoma+19 more
National Cancer Institute (NCI) 14
Early research (Phase 1)Ended earlyNCT03948763
What this trial is testing

MRNA-5671/V941 as Monotherapy and in Combination With Pembrolizumab (V941-001)

Who this might be right for
NeoplasmsCarcinoma, Non-Small-Cell LungPancreatic Neoplasms+1 more
Merck Sharp & Dohme LLC 70
Large-scale testing (Phase 3)UnknownNCT01515787
What this trial is testing

PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery

Who this might be right for
Colorectal Cancer
Alliance for Clinical Trials in Oncology 1,194
Testing effectiveness (Phase 2)Study completedNCT05535569
What this trial is testing

Phase Ib/II Study to Evaluate the Safety and Efficacy of Nivolumab in Combination With Paclitaxel in Epstein-Barr Virus(EBV)-Related, or Microsatellite Instability-High (MSI-H), or Programmed Cell Death Ligand 1 (PD-L1) Positive Advanced Gastric Cancer

Who this might be right for
Recurrent/Metastatic Gastric Cancer
Yonsei University 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT07818070
What this trial is testing

A Trial of ONO-4578 Versus Placebo in Combination With Nivolumab and Chemotherapy in Participants With Gastric Cancer, Esophagogastric Junction Cancer, or Esophageal Adenocarcinoma

Who this might be right for
Gastric CancerEsophagogastric Junction CancerEsophageal Adenocarcinoma
Ono Pharmaceutical Co., Ltd. 600
Testing effectiveness (Phase 2)Ended earlyNCT04424641
What this trial is testing

A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumor(s)Prostate CancerEsophageal Cancer+5 more
Genmab 48
Very early researchActive Not RecruitingNCT06853769
What this trial is testing

Neoadjuvant Therapy for Locally Advanced Rectal Cancer

Who this might be right for
Colorectal Cancer
The First Affiliated Hospital with Nanjing Medical University 48
Testing effectiveness (Phase 2)Study completedNCT00087503
What this trial is testing

Intravenous Edotecarin in Patients With Advanced Gastric Cancer That Has Progressed or Recurred After Chemotherapy

Who this might be right for
Stomach Neoplasms
Pfizer 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07655661
What this trial is testing

Mannatide Combined With CAPOX and Tislelizumab for Advanced Gastric Cancer.

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Ming Liu 52
Testing effectiveness (Phase 2)Study completedNCT04768686
What this trial is testing

FLX475 Combined With Pembrolizumab in Patients With Advanced or Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer
Hanmi Pharmaceutical Company Limited 20
Testing effectiveness (Phase 2)Looking for participantsNCT06761027
What this trial is testing

MFOLFIRINOX Plus Anlotinib and Sintilimab for Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic CancerMetastatic Pancreatic Cancer
Fujian Provincial Hospital 29
Testing effectiveness (Phase 2)Study completedNCT00382720
What this trial is testing

Docetaxel and Oxaliplatin in Gastric Cancer

Who this might be right for
Stomach Neoplasms
Sanofi 275
Early research (Phase 1)Study completedNCT00098982
What this trial is testing

Bortezomib, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC 16
Testing effectiveness (Phase 2)Study completedNCT00222469
What this trial is testing

Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
University of Oklahoma 50
Testing effectiveness (Phase 2)UnknownNCT02596256
What this trial is testing

Apatinib Plus Docetaxel Versus Docetaxel as Second-line Treatment in Advanced Gastric Cancer (AHEAD-301)

Who this might be right for
Gastric Cancer
Chinese PLA General Hospital 80
Testing effectiveness (Phase 2)UnknownNCT01234051
What this trial is testing

Docetaxel and Oxaliplatin Combination With Locally Advanced or Metastatic Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Korean South West Oncology Group 53
Not applicableStudy completedNCT02677129
What this trial is testing

Physical Function and Activities of Daily Living in Cancer Patients During Chemotherapy

Who this might be right for
Advanced Gastrointestinal Cancer
Goethe University 44
Testing effectiveness (Phase 2)UnknownNCT01100801
What this trial is testing

Genomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer Patients

Who this might be right for
Recurrent Gastric Cancer
National University Hospital, Singapore 90
Testing effectiveness (Phase 2)Looking for participantsNCT06385730
What this trial is testing

Neoadjuvant PD-1 Blockade for Elderly Esophageal Squamous Cell Carcinoma (BLESS)

Who this might be right for
Esophageal Cancer
Shanghai Chest Hospital 60
Testing effectiveness (Phase 2)UnknownNCT06394128
What this trial is testing

Cangpo Liujun Prescription on Cancer-related Fatigue in Advanced Colorectal Cancer With Spleen Deficiency and Dampness Excess

Who this might be right for
Cancer-Related FatigueColorectal Cancer
First People's Hospital of Hangzhou 48
Next Page